Praxsys Biosystems Inc.
This article was originally published in Start Up
Executive SummaryPraxsys's ReLIA is a simple, accurate point-of-care system for running sophisticated diagnostic tests -- including for hypothyroidism and routine, high-margin Ob/Gyn tests -- within the timeframe of an office visit to the physician. It is a next-generation immunoassay platform designed for ease of use and rapid output of results with the precision, accuracy, and reliability of central-laboratory tests.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.